A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.

NCT03564509 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Controlled Ovarian Stimulation

Interventions

DRUG: FE 999302 (1 μg) and follitropin delta
DRUG: FE 999302 (2 μg) and follitropin delta
DRUG: FE 999302 (4 μg) and follitropin delta
DRUG: FE 999302 (8 μg) and follitropin delta
DRUG: FE 999302 (12 μg) and follitropin delta
OTHER: Placebo and follitropin delta

Sponsor

Ferring Pharmaceuticals